Specifically, the experimental drug TEMPOL, administered orally, has shown promising results in the treatment of this disease, as suggested by the study done on cell cultures.
Researchers from United States they identified a possible new antiviral treatment cash against the covid-19, according to a study led by the governmental National Institutes of Health (NIH), published in the journal Science.
Specifically, the experimental drug TEMPOL, from oral administration, has thrown promising results in the treatment this disease, as suggested by the study done on cell cultures.
TEMPOL can limit the infection of virus SARS-CoV-2, al alterar the activity from viral enzyme named ARN replicasa, which allows the new coronavirus replicate your genome and make copies of itself once it is inside the cell.
ALSO READ: Good digestive health prevents the development of gastrointestinal cancer
In a statement, the NIH detailed that for wear a cape is investigation the scientists they tried Yes that enzyme requires of cumulus clouds from iron Y sulfide What medium of its structure.
And they found that in the case of SARS-CoV-2 bliss enzyme need of two clusters from iron Y sulfide to function optimally.
With this finding, researchers can exploit the weaknesses of viruyes, since TIMEL can reduce those cumulus clouds from iron Y sulfide.
ALSO READ: Risk of contracting Covid19 from newspapers and other surfaces is very low
In fact, they checked thanks to experiments in Cell cultures, that this medicine can inhibit the process from multiplication of virus.
In addition, based on previous studies of this drug in animals, it is possible that the doses of the drug used in antiviral experiments can be achieved in tissues that are the primary target of the coronavirus, such as the salivary glands and the lungs.